Capital Insight Partners’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,239	Closed	-$2.27M	–	174
2023 Q1	$2.27M	Buy	11,239 +198	+2%	+$44.9K	0.53%	66
2022 Q4	$2.41M	Buy	11,041 +136	+1%	+$29.7K	0.62%	57
2022 Q3	$2.15M	Buy	10,905 +80	+0.7%	+$17.3K	0.58%	60
2022 Q2	$2.32M	Buy	10,825 +503	+5%	+$123K	0.54%	62
2022 Q1	$2.93M	Buy	10,322 +1,048	+11%	+$323K	0.6%	58
2021 Q4	$3.49M	Buy	9,274 +933	+11%	+$362K	0.71%	49
2021 Q3	$3.44M	Sell	8,341 -177	-2%	-$73.5K	0.75%	42
2021 Q2	$3.15M	Buy	8,518 +6	+0.1%	+$2K	0.71%	47
2021 Q1	$2.47M	Sell	8,512 -34	-0.4%	-$9.45K	0.6%	65
2020 Q4	$2.13M	Sell	8,546 -11	-0.1%	-$2.62K	0.54%	72
2020 Q3	$1.94M	Sell	8,557 -4	-0%	-$830	0.54%	68
2020 Q2	$1.49M	Sell	8,561 -80	-0.9%	-$12.8K	0.47%	76
2020 Q1	$1.09M	Buy	8,641 +749	+9%	+$112K	0.58%	59
2019 Q4	$1.21M	Buy	7,892 +172	+2%	+$23.8K	0.55%	54
2019 Q3	$1.02M	Buy	7,720 +57	+0.7%	+$7.64K	0.89%	51
2019 Q2	$1.09M	Buy	+7,663	New	+$1.04M	0.94%	49